# Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

> **NCT05908006** · — · UNKNOWN · sponsor: **GI Alliance** · enrollment: 100 (estimated)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)

## Interventions

- **DEVICE:** Velacur

## Key facts

- **NCT ID:** NCT05908006
- **Lead sponsor:** GI Alliance
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908006, "Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05908006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
